Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Merck
Harvard Business School
Johnson and Johnson
McKinsey

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Claims for Patent: 8,987,554

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,987,554
Title:Cotton plant with seed-specific reduction in gossypol
Abstract: A method is disclosed for reducing the level of gossypol in cottonseed. The method generally includes selectively inducing RNA gene silencing in the seed of a transgenic cotton plant, to interfere with expression of the .delta.-cadinene synthase gene or the .delta.-cadinene-8-hydroxylase gene in the seed of the cotton plant without substantially affecting expression of that gene in the foliage, floral parts, and roots of the plant. The transgenic cotton plant comprises at least one of a .delta.-cadinene synthase gene trigger sequence and/or a .delta.-cadinene-8-hydroxylase gene trigger sequence operably linked to one or more a seed-specific promoter gene sequences, and the trigger sequence(s) is/are able to induce RNA gene silencing when expressed in cottonseed of the plant. Also disclosed are expression cassettes, vectors, cells, seeds, and plants containing at least one of a .delta.-cadinene synthase gene trigger sequence and/or a .delta.-cadinene-8-hydroxylase gene trigger sequence operably linked to one ore more a seed-specific promoter DNA sequences.
Inventor(s): Rathore; Keerti S. (College Station, TX), Sunilkumar; Ganesan (College Station, TX), Campbell; LeAnne M. (Cypress, TX)
Assignee: The Texas A&M University System (College Station, TX)
Application Number:13/109,682
Patent Claims:1. A method for reducing the level of gossypol in a seed of a cotton plant, the method comprising expressing in the seed a heterologous nucleic acid construct comprising a DNA sequence comprising at least 20 consecutive nucleotides of SEQ ID NO:1 and the reverse complement thereof operably linked to a seed-specific promoter DNA sequence, whereby RNA interference is substantially absent in parts of the cotton plant other than the seed, and wherein said expressing induces RNA interference-mediated reduction of gossypol levels in the seed.

2. The method of claim 1, wherein a level of gossypol in a tissue selected from the group consisting of foliage, leaves, bracts, buds, bolls, and roots of the treated cotton plant is substantially identical to the level of gossypol in a same tissue of a cotton plant not expressing the heterologous nucleic acid construct.

3. The method of claim 1, wherein the level of at least one terpenoid other than gossypol in a tissue selected from the group consisting of foliage, leaves, bracts, buds, bolls, and roots of the treated cotton plant is substantially identical to the level of the same at least one terpenoid in the same tissue of a cotton plant not expressing the heterologous nucleic acid construct.

4. The method of claim 1, wherein the heterologous nucleic acid construct comprises a transgene comprising a first nucleotide sequence, an intervening sequence, and a second nucleotide sequence comprising the reverse-complement of the first nucleotide sequence, and further wherein transcription of the transgene produces a hairpin RNA molecule comprising: (a) a double stranded region comprising an intermolecular hybridization of the first and second nucleotide sequences; and (b) a single stranded region comprising at least a part of the intervening sequence.

5. A method for producing a transgenic cotton plant bearing seed with a reduced gossypol content, the method comprising: (a) stably transforming a host cotton plant cell with an expression construct comprising a seed-specific promoter sequence operably linked to a DNA sequence comprising at least 20 consecutive nucleotides of SEQ ID NO:1 and the reverse-complement thereof; (b) regenerating a transgenic plant from the stably transformed host cotton plant cell; and (c) growing the transgenic plant under conditions whereby seed that express the expression construct are produced, wherein the seed have a reduced gossypol content as a result of the expression of the construct in the seed.

6. The method of claim 5, wherein the seed-specific promoter sequence comprises a nucleotide sequence as set forth in one of SEQ ID NOs: 10-12.

7. The method of claim 5, wherein expression of the DNA sequence disrupts cadinane sesquiterpenoid biosynthesis in the seed to a greater extent than it does in the foliage of the plant.

8. An expression cassette comprising: (a) a seed-specific promoter; (b) DNA sequence comprising at least 20 consecutive nucleotides of SEQ ID NO:1; (c) an intervening sequence; and (d) a sequence comprising a reverse-complement of the DNA sequence of (b), wherein elements (a)-(d) are positioned in relation to each other such that expression of the expression cassette in a cotton seed results in RNA interference-mediated reduction of-gossypol production in the cotton seed.

9. The expression cassette of claim 8, wherein the seed-specific promoter comprises an .alpha.-globulin B gene promoter.

10. The expression cassette of claim 8, wherein the intervening sequence comprises an intron.

11. A binary Agrobacterium tumefaciens vector for transforming a host cotton plant cell, wherein a T-DNA region of the vector comprises a seed-specific promoter operably linked to a DNA sequence encoding an intron-containing hairpin cassette comprising a DNA sequence comprising at least 20 consecutive nucleotides of SEQ ID NO:1 and the reverse-complement thereof wherein expression of the hairpin cassette in a cotton plant reduces the level of gossypol in the seed.

12. The binary Agrobacterium tumefaciens vector of claim 11, wherein the seed-specific promoter comprises an .alpha.-globulin B gene promoter.

13. The binary Agrobacterium tumefaciens vector of claim 12, wherein the .alpha.-globulin B gene promoter comprises SEQ ID NO: 10 or a functional fragment thereof.

14. The binary Agrobacterium tumefaciens vector of claim 11, wherein the T-DNA region comprises nucleotide sequences encoding: (a) a cotton .alpha.-globulin B gene promoter; (b) a first nucleotide sequence comprising at least 20 consecutive nucleotides of SEQ ID NO:1; (c) an intervening sequence; and (d) a second nucleotide sequence that comprises at least 20 consecutive nucleotides that can hybridize intramolecularly to (b).

15. The binary Agrobacterium tumefaciens vector of claim 14, wherein the T-DNA region further comprises a transcription terminator.

16. The binary Agrobacterium tumefaciens vector of claim 14, wherein the T-DNA region further comprises a selectable marker operably linked to a promoter that is active in a cotton cell.

17. The binary Agrobacterium tumefaciens vector of claim 11, wherein the T-DNA region comprises: (i) a cotton .alpha.-globulin B gene promoter; (ii) a first nucleotide sequence comprising at least 20 consecutive nucleotides of SEQ ID NO:1; (iii) an intervening sequence; (iv) a second nucleotide sequence that comprises at least 20 consecutive nucleotides that can hybridize intramolecularly to (ii); and (v) an octopine synthase terminator, wherein elements (i)-(v) are operably linked.

18. The binary Agrobacterium tumefaciens vector of claim 16, wherein the T-DNA region further comprises: (vi) a nopaline synthase promoter; (vii) a neomycin phosphotransferase II coding sequence; and (viii) a nopaline synthase terminator, wherein elements (vi)-(viii) are operably linked.

19. A transgenic cotton cell comprising the expression cassette of claim 8.

20. A transgenic cotton cell comprising the T-DNA of the binary Agrobacterium tumefaciens vector of claim 18.

21. A transgenic cotton plant produced by the method of claim 5, or the progeny thereof, wherein the transgenic cotton plant or progeny thereof comprises the expression construct.

22. Transgenic seed from the plant of claim 21, comprising the expression construct.

23. A transgenic cotton plant comprising the expression cassette of claim 8.

24. A seed from the plant of claim 23, comprising the expression cassette.

25. A kit comprising the expression cassette of claim 8 or the binary Agrobacterium tumefaciens vector of claim 11 and at least one reagent for introducing the expression cassette or the binary Agrobacterium tumefaciens vector into a plant cell.

26. The kit of claim 25, further comprising instructions for introducing the expression cassette or the binary Agrobacterium tumefaciens vector into a plant cell.

27. The binary Agrobacterium tumefaciens vector of claim 15, wherein the transcription terminator is selected from the group consisting of an octopine synthase terminator and a nopaline synthase terminator.

Details for Patent 8,987,554

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 1986-06-04 ⤷  Sign up for a Free Trial 2026-02-16
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Sign up for a Free Trial 2026-02-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Moodys
Boehringer Ingelheim
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.